nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—bone cancer	0.769	1	CbGaD
Sibutramine—Weight increased—Epirubicin—bone cancer	0.000247	0.00107	CcSEcCtD
Sibutramine—Haematuria—Methotrexate—bone cancer	0.000246	0.00107	CcSEcCtD
Sibutramine—Hyperglycaemia—Epirubicin—bone cancer	0.000245	0.00106	CcSEcCtD
Sibutramine—Angina pectoris—Doxorubicin—bone cancer	0.000244	0.00106	CcSEcCtD
Sibutramine—Epistaxis—Methotrexate—bone cancer	0.000244	0.00106	CcSEcCtD
Sibutramine—Pneumonia—Epirubicin—bone cancer	0.000243	0.00105	CcSEcCtD
Sibutramine—Bronchitis—Doxorubicin—bone cancer	0.000241	0.00105	CcSEcCtD
Sibutramine—Renal failure—Epirubicin—bone cancer	0.000238	0.00103	CcSEcCtD
Sibutramine—Body temperature increased—Cisplatin—bone cancer	0.000237	0.00103	CcSEcCtD
Sibutramine—Neuropathy peripheral—Epirubicin—bone cancer	0.000237	0.00103	CcSEcCtD
Sibutramine—Stomatitis—Epirubicin—bone cancer	0.000236	0.00102	CcSEcCtD
Sibutramine—Conjunctivitis—Epirubicin—bone cancer	0.000235	0.00102	CcSEcCtD
Sibutramine—Urinary tract infection—Epirubicin—bone cancer	0.000235	0.00102	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—bone cancer	0.000235	0.00102	CcSEcCtD
Sibutramine—Haemoglobin—Methotrexate—bone cancer	0.000233	0.00101	CcSEcCtD
Sibutramine—Haemorrhage—Methotrexate—bone cancer	0.000232	0.00101	CcSEcCtD
Sibutramine—Sweating—Epirubicin—bone cancer	0.000232	0.001	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—bone cancer	0.000232	0.001	CcSEcCtD
Sibutramine—Haematuria—Epirubicin—bone cancer	0.000231	0.000999	CcSEcCtD
Sibutramine—Pharyngitis—Methotrexate—bone cancer	0.00023	0.000998	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000229	0.000992	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—bone cancer	0.000228	0.00099	CcSEcCtD
Sibutramine—Epistaxis—Epirubicin—bone cancer	0.000228	0.000988	CcSEcCtD
Sibutramine—Sinusitis—Epirubicin—bone cancer	0.000227	0.000983	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—bone cancer	0.000226	0.000981	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—bone cancer	0.000225	0.000975	CcSEcCtD
Sibutramine—Visual impairment—Methotrexate—bone cancer	0.000224	0.000969	CcSEcCtD
Sibutramine—Hypersensitivity—Cisplatin—bone cancer	0.000221	0.000959	CcSEcCtD
Sibutramine—Bradycardia—Epirubicin—bone cancer	0.000221	0.000958	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—bone cancer	0.00022	0.000953	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000219	0.00095	CcSEcCtD
Sibutramine—Haemoglobin—Epirubicin—bone cancer	0.000218	0.000945	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—bone cancer	0.000218	0.000945	CcSEcCtD
Sibutramine—Rhinitis—Epirubicin—bone cancer	0.000218	0.000943	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—bone cancer	0.000217	0.000942	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—bone cancer	0.000217	0.000942	CcSEcCtD
Sibutramine—Haemorrhage—Epirubicin—bone cancer	0.000217	0.000941	CcSEcCtD
Sibutramine—Eye disorder—Methotrexate—bone cancer	0.000217	0.000939	CcSEcCtD
Sibutramine—Tinnitus—Methotrexate—bone cancer	0.000216	0.000937	CcSEcCtD
Sibutramine—Hypoaesthesia—Epirubicin—bone cancer	0.000216	0.000936	CcSEcCtD
Sibutramine—Asthenia—Cisplatin—bone cancer	0.000215	0.000934	CcSEcCtD
Sibutramine—Pharyngitis—Epirubicin—bone cancer	0.000215	0.000934	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—bone cancer	0.000214	0.000929	CcSEcCtD
Sibutramine—Oedema peripheral—Epirubicin—bone cancer	0.000214	0.000927	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—bone cancer	0.000213	0.000924	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—bone cancer	0.000211	0.000914	CcSEcCtD
Sibutramine—Angiopathy—Methotrexate—bone cancer	0.00021	0.000912	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—bone cancer	0.00021	0.00091	CcSEcCtD
Sibutramine—Immune system disorder—Methotrexate—bone cancer	0.000209	0.000908	CcSEcCtD
Sibutramine—Visual impairment—Epirubicin—bone cancer	0.000209	0.000906	CcSEcCtD
Sibutramine—Chills—Methotrexate—bone cancer	0.000208	0.000902	CcSEcCtD
Sibutramine—Diarrhoea—Cisplatin—bone cancer	0.000205	0.00089	CcSEcCtD
Sibutramine—Alopecia—Methotrexate—bone cancer	0.000205	0.000888	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—bone cancer	0.000204	0.000886	CcSEcCtD
Sibutramine—Eye disorder—Epirubicin—bone cancer	0.000203	0.000879	CcSEcCtD
Sibutramine—Tinnitus—Epirubicin—bone cancer	0.000202	0.000877	CcSEcCtD
Sibutramine—Malnutrition—Methotrexate—bone cancer	0.000202	0.000875	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—bone cancer	0.000202	0.000875	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—bone cancer	0.000201	0.000873	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—bone cancer	0.000201	0.00087	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—bone cancer	0.0002	0.000866	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—bone cancer	0.000199	0.000864	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—bone cancer	0.000198	0.000857	CcSEcCtD
Sibutramine—Dysgeusia—Methotrexate—bone cancer	0.000198	0.000857	CcSEcCtD
Sibutramine—Angiopathy—Epirubicin—bone cancer	0.000197	0.000853	CcSEcCtD
Sibutramine—Immune system disorder—Epirubicin—bone cancer	0.000196	0.00085	CcSEcCtD
Sibutramine—Back pain—Methotrexate—bone cancer	0.000195	0.000846	CcSEcCtD
Sibutramine—Chills—Epirubicin—bone cancer	0.000195	0.000844	CcSEcCtD
Sibutramine—Arrhythmia—Epirubicin—bone cancer	0.000194	0.00084	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—bone cancer	0.000194	0.000839	CcSEcCtD
Sibutramine—Alopecia—Epirubicin—bone cancer	0.000192	0.000831	CcSEcCtD
Sibutramine—Vomiting—Cisplatin—bone cancer	0.000191	0.000827	CcSEcCtD
Sibutramine—Vision blurred—Methotrexate—bone cancer	0.00019	0.000825	CcSEcCtD
Sibutramine—Rash—Cisplatin—bone cancer	0.000189	0.00082	CcSEcCtD
Sibutramine—Dermatitis—Cisplatin—bone cancer	0.000189	0.00082	CcSEcCtD
Sibutramine—Malnutrition—Epirubicin—bone cancer	0.000189	0.000819	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—bone cancer	0.000188	0.000813	CcSEcCtD
Sibutramine—Ill-defined disorder—Methotrexate—bone cancer	0.000187	0.000812	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—bone cancer	0.000187	0.000811	CcSEcCtD
Sibutramine—Anaemia—Methotrexate—bone cancer	0.000187	0.000809	CcSEcCtD
Sibutramine—Flatulence—Epirubicin—bone cancer	0.000186	0.000807	CcSEcCtD
Sibutramine—Tension—Epirubicin—bone cancer	0.000185	0.000803	CcSEcCtD
Sibutramine—Dysgeusia—Epirubicin—bone cancer	0.000185	0.000802	CcSEcCtD
Sibutramine—Nervousness—Epirubicin—bone cancer	0.000184	0.000795	CcSEcCtD
Sibutramine—Back pain—Epirubicin—bone cancer	0.000183	0.000792	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—bone cancer	0.000182	0.00079	CcSEcCtD
Sibutramine—Malaise—Methotrexate—bone cancer	0.000182	0.000789	CcSEcCtD
Sibutramine—Muscle spasms—Epirubicin—bone cancer	0.000182	0.000787	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—bone cancer	0.000181	0.000786	CcSEcCtD
Sibutramine—Vertigo—Methotrexate—bone cancer	0.000181	0.000786	CcSEcCtD
Sibutramine—Leukopenia—Methotrexate—bone cancer	0.000181	0.000783	CcSEcCtD
Sibutramine—Chills—Doxorubicin—bone cancer	0.00018	0.000781	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—bone cancer	0.000179	0.000777	CcSEcCtD
Sibutramine—Nausea—Cisplatin—bone cancer	0.000178	0.000773	CcSEcCtD
Sibutramine—Vision blurred—Epirubicin—bone cancer	0.000178	0.000772	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—bone cancer	0.000177	0.000769	CcSEcCtD
Sibutramine—Cough—Methotrexate—bone cancer	0.000176	0.000763	CcSEcCtD
Sibutramine—Ill-defined disorder—Epirubicin—bone cancer	0.000175	0.00076	CcSEcCtD
Sibutramine—Convulsion—Methotrexate—bone cancer	0.000175	0.000758	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—bone cancer	0.000175	0.000758	CcSEcCtD
Sibutramine—Anaemia—Epirubicin—bone cancer	0.000175	0.000757	CcSEcCtD
Sibutramine—Agitation—Epirubicin—bone cancer	0.000174	0.000752	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—bone cancer	0.000172	0.000747	CcSEcCtD
Sibutramine—Arthralgia—Methotrexate—bone cancer	0.000172	0.000745	CcSEcCtD
Sibutramine—Chest pain—Methotrexate—bone cancer	0.000172	0.000745	CcSEcCtD
Sibutramine—Myalgia—Methotrexate—bone cancer	0.000172	0.000745	CcSEcCtD
Sibutramine—Tension—Doxorubicin—bone cancer	0.000172	0.000743	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—bone cancer	0.000171	0.000742	CcSEcCtD
Sibutramine—Malaise—Epirubicin—bone cancer	0.00017	0.000738	CcSEcCtD
Sibutramine—Discomfort—Methotrexate—bone cancer	0.00017	0.000736	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—bone cancer	0.00017	0.000736	CcSEcCtD
Sibutramine—Vertigo—Epirubicin—bone cancer	0.00017	0.000736	CcSEcCtD
Sibutramine—Syncope—Epirubicin—bone cancer	0.000169	0.000734	CcSEcCtD
Sibutramine—Leukopenia—Epirubicin—bone cancer	0.000169	0.000733	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—bone cancer	0.000169	0.000733	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—bone cancer	0.000168	0.000728	CcSEcCtD
Sibutramine—Palpitations—Epirubicin—bone cancer	0.000167	0.000724	CcSEcCtD
Sibutramine—Confusional state—Methotrexate—bone cancer	0.000166	0.00072	CcSEcCtD
Sibutramine—Loss of consciousness—Epirubicin—bone cancer	0.000166	0.00072	CcSEcCtD
Sibutramine—Cough—Epirubicin—bone cancer	0.000165	0.000714	CcSEcCtD
Sibutramine—Anaphylactic shock—Methotrexate—bone cancer	0.000165	0.000714	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—bone cancer	0.000165	0.000714	CcSEcCtD
Sibutramine—Convulsion—Epirubicin—bone cancer	0.000164	0.000709	CcSEcCtD
Sibutramine—Infection—Methotrexate—bone cancer	0.000164	0.000709	CcSEcCtD
Sibutramine—Hypertension—Epirubicin—bone cancer	0.000163	0.000707	CcSEcCtD
Sibutramine—Ill-defined disorder—Doxorubicin—bone cancer	0.000162	0.000703	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—bone cancer	0.000162	0.0007	CcSEcCtD
Sibutramine—Thrombocytopenia—Methotrexate—bone cancer	0.000161	0.000699	CcSEcCtD
Sibutramine—Arthralgia—Epirubicin—bone cancer	0.000161	0.000697	CcSEcCtD
Sibutramine—Myalgia—Epirubicin—bone cancer	0.000161	0.000697	CcSEcCtD
Sibutramine—Chest pain—Epirubicin—bone cancer	0.000161	0.000697	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—bone cancer	0.000161	0.000696	CcSEcCtD
Sibutramine—Anxiety—Epirubicin—bone cancer	0.00016	0.000695	CcSEcCtD
Sibutramine—Skin disorder—Methotrexate—bone cancer	0.00016	0.000694	CcSEcCtD
Sibutramine—Hyperhidrosis—Methotrexate—bone cancer	0.000159	0.00069	CcSEcCtD
Sibutramine—Discomfort—Epirubicin—bone cancer	0.000159	0.000689	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—bone cancer	0.000158	0.000683	CcSEcCtD
Sibutramine—Dry mouth—Epirubicin—bone cancer	0.000157	0.000682	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—bone cancer	0.000157	0.000681	CcSEcCtD
Sibutramine—Anorexia—Methotrexate—bone cancer	0.000157	0.000681	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—bone cancer	0.000157	0.000679	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—bone cancer	0.000156	0.000678	CcSEcCtD
Sibutramine—Confusional state—Epirubicin—bone cancer	0.000155	0.000674	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—bone cancer	0.000155	0.00067	CcSEcCtD
Sibutramine—Oedema—Epirubicin—bone cancer	0.000154	0.000668	CcSEcCtD
Sibutramine—Anaphylactic shock—Epirubicin—bone cancer	0.000154	0.000668	CcSEcCtD
Sibutramine—Hypotension—Methotrexate—bone cancer	0.000154	0.000667	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—bone cancer	0.000154	0.000666	CcSEcCtD
Sibutramine—Infection—Epirubicin—bone cancer	0.000153	0.000664	CcSEcCtD
Sibutramine—Cough—Doxorubicin—bone cancer	0.000153	0.000661	CcSEcCtD
Sibutramine—Shock—Epirubicin—bone cancer	0.000152	0.000657	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—bone cancer	0.000151	0.000656	CcSEcCtD
Sibutramine—Thrombocytopenia—Epirubicin—bone cancer	0.000151	0.000654	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—bone cancer	0.000151	0.000654	CcSEcCtD
Sibutramine—Tachycardia—Epirubicin—bone cancer	0.000151	0.000652	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00015	0.000651	CcSEcCtD
Sibutramine—Skin disorder—Epirubicin—bone cancer	0.00015	0.000649	CcSEcCtD
Sibutramine—Hyperhidrosis—Epirubicin—bone cancer	0.000149	0.000646	CcSEcCtD
Sibutramine—Insomnia—Methotrexate—bone cancer	0.000149	0.000646	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—bone cancer	0.000149	0.000645	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—bone cancer	0.000149	0.000645	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—bone cancer	0.000149	0.000645	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—bone cancer	0.000148	0.000643	CcSEcCtD
Sibutramine—Paraesthesia—Methotrexate—bone cancer	0.000148	0.000641	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—bone cancer	0.000147	0.000637	CcSEcCtD
Sibutramine—Anorexia—Epirubicin—bone cancer	0.000147	0.000637	CcSEcCtD
Sibutramine—Dyspnoea—Methotrexate—bone cancer	0.000147	0.000637	CcSEcCtD
Sibutramine—Somnolence—Methotrexate—bone cancer	0.000146	0.000635	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—bone cancer	0.000146	0.000631	CcSEcCtD
Sibutramine—Dyspepsia—Methotrexate—bone cancer	0.000145	0.000629	CcSEcCtD
Sibutramine—Hypotension—Epirubicin—bone cancer	0.000144	0.000624	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—bone cancer	0.000144	0.000623	CcSEcCtD
Sibutramine—Decreased appetite—Methotrexate—bone cancer	0.000143	0.000621	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—bone cancer	0.000143	0.000618	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—bone cancer	0.000143	0.000618	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000142	0.000616	CcSEcCtD
Sibutramine—Infection—Doxorubicin—bone cancer	0.000142	0.000614	CcSEcCtD
Sibutramine—Pain—Methotrexate—bone cancer	0.000141	0.000611	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00014	0.000609	CcSEcCtD
Sibutramine—Shock—Doxorubicin—bone cancer	0.00014	0.000608	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—bone cancer	0.00014	0.000605	CcSEcCtD
Sibutramine—Insomnia—Epirubicin—bone cancer	0.000139	0.000604	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—bone cancer	0.000139	0.000603	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—bone cancer	0.000139	0.000601	CcSEcCtD
Sibutramine—Paraesthesia—Epirubicin—bone cancer	0.000138	0.0006	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—bone cancer	0.000138	0.000598	CcSEcCtD
Sibutramine—Dyspnoea—Epirubicin—bone cancer	0.000137	0.000596	CcSEcCtD
Sibutramine—Somnolence—Epirubicin—bone cancer	0.000137	0.000594	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—bone cancer	0.000136	0.000589	CcSEcCtD
Sibutramine—Feeling abnormal—Methotrexate—bone cancer	0.000136	0.000588	CcSEcCtD
Sibutramine—Dyspepsia—Epirubicin—bone cancer	0.000136	0.000588	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methotrexate—bone cancer	0.000135	0.000584	CcSEcCtD
Sibutramine—Decreased appetite—Epirubicin—bone cancer	0.000134	0.000581	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—bone cancer	0.000133	0.000578	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000133	0.000577	CcSEcCtD
Sibutramine—Constipation—Epirubicin—bone cancer	0.000132	0.000571	CcSEcCtD
Sibutramine—Pain—Epirubicin—bone cancer	0.000132	0.000571	CcSEcCtD
Sibutramine—Urticaria—Methotrexate—bone cancer	0.000131	0.000567	CcSEcCtD
Sibutramine—Body temperature increased—Methotrexate—bone cancer	0.00013	0.000564	CcSEcCtD
Sibutramine—Abdominal pain—Methotrexate—bone cancer	0.00013	0.000564	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00013	0.000563	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—bone cancer	0.000129	0.000559	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—bone cancer	0.000128	0.000555	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—bone cancer	0.000127	0.000551	CcSEcCtD
Sibutramine—Feeling abnormal—Epirubicin—bone cancer	0.000127	0.000551	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—bone cancer	0.000127	0.00055	CcSEcCtD
Sibutramine—Gastrointestinal pain—Epirubicin—bone cancer	0.000126	0.000546	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—bone cancer	0.000126	0.000544	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—bone cancer	0.000124	0.000537	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000123	0.000534	CcSEcCtD
Sibutramine—Urticaria—Epirubicin—bone cancer	0.000123	0.000531	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—bone cancer	0.000122	0.000529	CcSEcCtD
Sibutramine—Pain—Doxorubicin—bone cancer	0.000122	0.000529	CcSEcCtD
Sibutramine—Abdominal pain—Epirubicin—bone cancer	0.000122	0.000528	CcSEcCtD
Sibutramine—Body temperature increased—Epirubicin—bone cancer	0.000122	0.000528	CcSEcCtD
Sibutramine—Hypersensitivity—Methotrexate—bone cancer	0.000121	0.000526	CcSEcCtD
Sibutramine—Asthenia—Methotrexate—bone cancer	0.000118	0.000512	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—bone cancer	0.000118	0.00051	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000117	0.000506	CcSEcCtD
Sibutramine—Pruritus—Methotrexate—bone cancer	0.000117	0.000505	CcSEcCtD
Sibutramine—Hypersensitivity—Epirubicin—bone cancer	0.000114	0.000492	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—bone cancer	0.000113	0.000491	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—bone cancer	0.000113	0.000489	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—bone cancer	0.000113	0.000489	CcSEcCtD
Sibutramine—Diarrhoea—Methotrexate—bone cancer	0.000113	0.000489	CcSEcCtD
Sibutramine—Asthenia—Epirubicin—bone cancer	0.000111	0.000479	CcSEcCtD
Sibutramine—Pruritus—Epirubicin—bone cancer	0.000109	0.000473	CcSEcCtD
Sibutramine—Dizziness—Methotrexate—bone cancer	0.000109	0.000472	CcSEcCtD
Sibutramine—Diarrhoea—Epirubicin—bone cancer	0.000106	0.000457	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—bone cancer	0.000105	0.000456	CcSEcCtD
Sibutramine—Vomiting—Methotrexate—bone cancer	0.000105	0.000454	CcSEcCtD
Sibutramine—Rash—Methotrexate—bone cancer	0.000104	0.00045	CcSEcCtD
Sibutramine—Dermatitis—Methotrexate—bone cancer	0.000104	0.00045	CcSEcCtD
Sibutramine—Headache—Methotrexate—bone cancer	0.000103	0.000447	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—bone cancer	0.000102	0.000444	CcSEcCtD
Sibutramine—Dizziness—Epirubicin—bone cancer	0.000102	0.000442	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—bone cancer	0.000101	0.000437	CcSEcCtD
Sibutramine—Vomiting—Epirubicin—bone cancer	9.8e-05	0.000425	CcSEcCtD
Sibutramine—Nausea—Methotrexate—bone cancer	9.79e-05	0.000424	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—bone cancer	9.76e-05	0.000423	CcSEcCtD
Sibutramine—Rash—Epirubicin—bone cancer	9.72e-05	0.000421	CcSEcCtD
Sibutramine—Dermatitis—Epirubicin—bone cancer	9.71e-05	0.000421	CcSEcCtD
Sibutramine—Headache—Epirubicin—bone cancer	9.66e-05	0.000419	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—bone cancer	9.44e-05	0.000409	CcSEcCtD
Sibutramine—Nausea—Epirubicin—bone cancer	9.16e-05	0.000397	CcSEcCtD
Sibutramine—Vomiting—Doxorubicin—bone cancer	9.07e-05	0.000393	CcSEcCtD
Sibutramine—Rash—Doxorubicin—bone cancer	9e-05	0.00039	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—bone cancer	8.99e-05	0.000389	CcSEcCtD
Sibutramine—Headache—Doxorubicin—bone cancer	8.94e-05	0.000387	CcSEcCtD
Sibutramine—Nausea—Doxorubicin—bone cancer	8.48e-05	0.000367	CcSEcCtD
